Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 257

1.

Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.

Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H.

J Clin Psychiatry. 2005 Mar;66(3):370-4.

PMID:
15766304
[PubMed - indexed for MEDLINE]
2.

Levetiracetam for treatment-refractory posttraumatic stress disorder.

Kinrys G, Wygant LE, Pardo TB, Melo M.

J Clin Psychiatry. 2006 Feb;67(2):211-4.

PMID:
16566615
[PubMed - indexed for MEDLINE]
3.

An open-label study of levetiracetam for the treatment of social anxiety disorder.

Simon NM, Worthington JJ, Doyle AC, Hoge EA, Kinrys G, Fischmann D, Link N, Pollack MH.

J Clin Psychiatry. 2004 Sep;65(9):1219-22.

PMID:
15367048
[PubMed - indexed for MEDLINE]
4.

Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.

Bowden CL, Myers JE, Grossman F, Xie Y.

J Clin Psychiatry. 2004 May;65(5):707-14.

PMID:
15163260
[PubMed - indexed for MEDLINE]
5.

A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder.

Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, Sureddi S, Allen JC.

J Clin Psychiatry. 2008 Feb;69(2):183-9.

PMID:
18211128
[PubMed - indexed for MEDLINE]
6.

Levetiracetam as adjunctive therapy for refractory anxiety disorders.

Kinrys G, Worthington JJ, Wygant L, Nery F, Reese H, Pollack MH.

J Clin Psychiatry. 2007 Jul;68(7):1010-3.

PMID:
17685735
[PubMed - indexed for MEDLINE]
7.

An open trial of adjunctive escitalopram in bipolar depression.

Fonseca M, Soares JC, Hatch JP, Santin AP, Kapczinski F.

J Clin Psychiatry. 2006 Jan;67(1):81-6.

PMID:
16426092
[PubMed - indexed for MEDLINE]
8.

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

Amsterdam JD, Wang CH, Shwarz M, Shults J.

J Affect Disord. 2009 Jan;112(1-3):219-30. doi: 10.1016/j.jad.2008.03.029. Epub 2008 May 16.

PMID:
18486235
[PubMed - indexed for MEDLINE]
9.

Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.

Suppes T, Brown E, Schuh LM, Baker RW, Tohen M.

J Affect Disord. 2005 Dec;89(1-3):69-77. Epub 2005 Oct 25.

PMID:
16253344
[PubMed - indexed for MEDLINE]
10.

A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients.

Anand A, Bukhari L, Jennings SA, Lee C, Kamat M, Shekhar A, Nurnberger JI Jr, Lightfoot J.

J Clin Psychiatry. 2005 Feb;66(2):195-8.

PMID:
15705004
[PubMed - indexed for MEDLINE]
11.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63. Epub 2007 Mar 26.

PMID:
17383736
[PubMed - indexed for MEDLINE]
12.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14. Epub 2007 Mar 27.

PMID:
17391773
[PubMed - indexed for MEDLINE]
13.

Role of risperidone in bipolar II: an open 6-month study.

Vieta E, Gastó C, Colom F, Reinares M, Martínez-Arán A, Benabarre A, Akiskal HS.

J Affect Disord. 2001 Dec;67(1-3):213-9.

PMID:
11869771
[PubMed - indexed for MEDLINE]
14.

Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.

Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D; European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.

J Clin Psychiatry. 2010 Mar;71(3):255-61. doi: 10.4088/JCP.08m04580. Epub 2009 Aug 25.

PMID:
19709503
[PubMed - indexed for MEDLINE]
15.

Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Keck PE Jr, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.

J Clin Psychiatry. 2005 May;66(5):611-6.

PMID:
15889948
[PubMed - indexed for MEDLINE]
16.

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM.

Int Clin Psychopharmacol. 2006 Jan;21(1):11-20.

PMID:
16317312
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.

Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.

Epilepsy Res. 2005 Jan;63(1):1-9. Epub 2005 Jan 6.

PMID:
15716083
[PubMed - indexed for MEDLINE]
18.

Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.

Grunze H, Langosch J, Born C, Schaub G, Walden J.

J Clin Psychiatry. 2003 Jul;64(7):781-4.

PMID:
12934978
[PubMed - indexed for MEDLINE]
19.

Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.

Papp LA.

J Clin Psychiatry. 2006 Oct;67(10):1573-6.

PMID:
17107249
[PubMed - indexed for MEDLINE]
20.

Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).

Vieta E, Angst J, Reed C, Bertsch J, Haro JM; EMBLEM advisory board.

J Affect Disord. 2009 Nov;118(1-3):118-23. doi: 10.1016/j.jad.2009.02.007. Epub 2009 Mar 9.

PMID:
19269690
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk